通过T2*磁共振成像评估的心脏铁过载与定期输血的骨髓增生异常综合征患者的心脏功能 - Suppr

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.

作者信息

Pascal Laurent, Beyne-Rauzy Odile, Brechignac Sabine, Marechaux Sylvestre, Vassilieff Dominique, Ernst Olivier, Berthon Céline, Gyan Emmanuel, Gourin Marie-Pierre, Dreyfus François, Fenaux Pierre, Rose Christian

出版信息

Br J Haematol. 2013 Aug;162(3):413-5. doi: 10.1111/bjh.12368. Epub 2013 May 9.

DOI:10.1111/bjh.12368

PMID:23656172

Abstract

摘要

相似文献

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.通过T2*磁共振成像评估的心脏铁过载与定期输血的骨髓增生异常综合征患者的心脏功能

Br J Haematol. 2013 Aug;162(3):413-5. doi: 10.1111/bjh.12368. Epub 2013 May 9.

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.通过T2*磁共振成像评估的心脏铁过载与接受定期输血的骨髓增生异常综合征患者的心脏功能

Br J Haematol. 2014 Feb;164(4):610-1. doi: 10.1111/bjh.12655. Epub 2013 Nov 15.

Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.通过磁共振成像T2*评估长期输血的预后良好的骨髓增生异常综合征患者的心肌铁负荷。

Br J Haematol. 2007 Sep;138(5):587-93. doi: 10.1111/j.1365-2141.2007.06695.x. Epub 2007 Jul 4.

No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique.使用心脏磁共振T2技术，未发现骨髓增生异常综合征多次输血患者存在心肌铁过载的证据。

Am J Hematol. 2007 Nov;82(11):1013-6. doi: 10.1002/ajh.20980.

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients, the GFM experience: response to Bowen et al.通过T2*磁共振成像评估的心脏铁过载及定期输血的骨髓增生异常综合征患者的心脏功能，GFM经验：对鲍文等人的回应

Br J Haematol. 2014 Feb;164(4):612-3. doi: 10.1111/bjh.12653. Epub 2013 Nov 9.

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.一项为期 1 年、开放性、单臂、多中心试验的结果，评估了口服地拉罗司在低危和中危-1 风险骨髓增生异常综合征（MDS）和输血依赖型铁过载患者中的疗效和安全性。

Ann Hematol. 2013 Jan;92(2):191-8. doi: 10.1007/s00277-012-1594-z. Epub 2012 Oct 17.

Deferasirox in MDS patients with transfusion-caused iron overload--a phase-II study.地拉罗司用于治疗因输血导致铁过载的骨髓增生异常综合征患者——一项II期研究。

Ann Hematol. 2009 Apr;88(4):301-10. doi: 10.1007/s00277-008-0588-3. Epub 2008 Aug 29.

Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.骨髓增生异常综合征患者经T2*磁共振成像（MRI）检测的肝脏、心脏铁过载情况：一项横断面研究

Leuk Res. 2019 Jan;76:53-57. doi: 10.1016/j.leukres.2018.12.001. Epub 2018 Dec 4.

Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.输血依赖型骨髓增生异常综合征患者的心脏铁过载。

Br J Haematol. 2011 Aug;154(4):521-4. doi: 10.1111/j.1365-2141.2011.08749.x. Epub 2011 Jun 21.

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.铁状态和输血依赖型骨髓增生异常综合征患者的治疗方式。

Ann Hematol. 2011 Jun;90(6):655-66. doi: 10.1007/s00277-011-1164-9. Epub 2011 Feb 12.

引用本文的文献

Iron overload in acquired sideroblastic anemias and MDS: pathophysiology and role of chelation and luspatercept.获得性铁粒幼细胞贫血和骨髓增生异常综合征中的铁过载：病理生理学以及螯合作用和罗特西普的作用

Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):443-449. doi: 10.1182/hematology.2024000569.

Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes.低危骨髓增生异常综合征的当前治疗现状。

Curr Treat Options Oncol. 2023 May;24(5):387-408. doi: 10.1007/s11864-023-01062-7. Epub 2023 Mar 25.

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients.骨髓增生异常综合征患者铁螯合治疗的预后因素及临床考量

J Blood Med. 2021 Dec 3;12:1019-1030. doi: 10.2147/JBM.S287876. eCollection 2021.

Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network.骨髓增生异常综合征患者前瞻性心脏磁共振成像调查：来自意大利网络的见解。

Ann Hematol. 2021 May;100(5):1139-1147. doi: 10.1007/s00277-021-04495-y. Epub 2021 Mar 19.

Controversies on the Consequences of Iron Overload and Chelation in MDS.骨髓增生异常综合征中铁过载及螯合治疗后果的争议

Hemasphere. 2020 May 27;4(3):e357. doi: 10.1097/HS9.0000000000000357. eCollection 2020 Jun.

[Study of iron overload assessment by T2* magnetic resonance imaging in patients with myelodysplastic syndromes].[骨髓增生异常综合征患者铁过载评估的T2*磁共振成像研究]

Zhonghua Xue Ye Xue Za Zhi. 2019 Mar 14;40(3):222-226. doi: 10.3760/cma.j.issn.0253-2727.2019.03.011.

Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment.骨髓增生异常综合征中的铁过载：病理生理学、后果、诊断及治疗

J Adv Pract Oncol. 2018 May-Jun;9(4):392-405. Epub 2018 May 1.

Iron overload in myelodysplastic syndromes (MDS).骨髓增生异常综合征（MDS）中的铁过载

Int J Hematol. 2018 Jan;107(1):55-63. doi: 10.1007/s12185-017-2367-1. Epub 2017 Nov 25.

Myelodysplastic Syndromes and Iron Chelation Therapy.骨髓增生异常综合征与铁螯合疗法

Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017021. doi: 10.4084/MJHID.2017.021. eCollection 2017.

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.患有地中海贫血、镰状细胞贫血或骨髓增生异常综合征的长期输血患者的心脏铁过载。

PLoS One. 2017 Mar 3;12(3):e0172147. doi: 10.1371/journal.pone.0172147. eCollection 2017.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献